Drugplain

Meijer Ultra Strength Pain Relieving Topical Analgesic 40 mg/g

CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate · CREAM · Meijer Distribution, Inc

No Recall History
Plain English

Meijer Ultra Strength Pain Relieving Topical Analgesic is a cream containing camphor (synthetic), menthol, unspecified form, and methyl salicylate at 40 mg/g, taken topical. Manufactured by Meijer Distribution, Inc.

Key Facts

Brand Name
Meijer Ultra Strength Pain Relieving Topical Analgesic
Generic Name
CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate
NDC Code (Product)
79481-1220
Manufacturer
Meijer Distribution, Inc
Strength
40 mg/g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M017
Marketing Start
11/30/2020

Recall History

No Recall History

Frequently Asked Questions

What is Meijer Ultra Strength Pain Relieving Topical Analgesic used for?

Meijer Ultra Strength Pain Relieving Topical Analgesic contains CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate. It is a cream taken topical. Consult your doctor for specific uses.

Is Meijer Ultra Strength Pain Relieving Topical Analgesic a controlled substance?

Meijer Ultra Strength Pain Relieving Topical Analgesic is not classified as a controlled substance by the DEA.

What is the generic name for Meijer Ultra Strength Pain Relieving Topical Analgesic?

The generic name for Meijer Ultra Strength Pain Relieving Topical Analgesic is CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate. There are 3 other brand versions of CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate.

What is the NDC code for Meijer Ultra Strength Pain Relieving Topical Analgesic 40 mg/g?

The NDC (National Drug Code) for Meijer Ultra Strength Pain Relieving Topical Analgesic 40 mg/g is 79481-1220, listed by Meijer Distribution, Inc.

Product NDC

79481-1220

Package NDC

79481-1220-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)